Montecito Bank & Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-6,393
Closed -$1.07M 386
2016
Q3
$1.07M Buy
6,393
+412
+7% +$69.7K 0.44% 58
2016
Q2
$910K Buy
5,981
+1,116
+23% +$174K 0.38% 59
2016
Q1
$729K Buy
4,865
+254
+6% +$37.7K 0.33% 57
2015
Q4
$749K Buy
4,611
+1,206
+35% +$190K 0.35% 55
2015
Q3
$471K Buy
3,405
+450
+15% +$70.9K 0.26% 75
2015
Q2
$472K Hold
2,955
0.23% 87
2015
Q1
$472K Buy
2,955
+13
+0.4% +$2.05K 0.23% 87
2014
Q4
$469K Sell
2,942
-37
-1% -$5.76K 0.25% 86
2014
Q3
$418K Sell
2,979
-334
-10% -$43.6K 0.25% 82
2014
Q2
$392K Sell
3,313
-32
-1% -$3.7K 0.24% 87
2014
Q1
$413K Buy
3,345
+203
+6% +$24.6K 0.26% 80
2013
Q4
$358K Buy
3,142
+189
+6% +$21.5K 0.22% 90
2013
Q3
$330K Sell
2,953
-162
-5% -$17.6K 0.22% 89
2013
Q2
$307K Buy
+3,115
New +$323K 0.21% 91

Other funds holding AMGN

Montecito Bank & Trust's AMGN Position: Q4 2016 in Review

Montecito Bank & Trust sold out of Amgen (AMGN) in Q4 2016, closing a stake of 6,393 shares — an estimated $1.07M sold.

Montecito Bank & Trust first reported a position in AMGN in Q2 2013 and held it in 14 quarters. The position peaked at $1.07M in Q3 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • Montecito Bank & Trust reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • Montecito Bank & Trust sold 6,393 Amgen shares in Q4 2016, an estimated $1.07M.
  • Montecito Bank & Trust first reported a position in Amgen in Q2 2013 and held it in 14 quarters.
  • Montecito Bank & Trust's Amgen position peaked at $1.07M in Q3 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on Montecito Bank & Trust's 13F filing for Q4 2016, filed 15 Feb 2017.